CliniShift, a digital platform that enables hospital schedulers to fill vacant shifts at short notice with qualified clinical staff, eliminates the need for high-cost agency staff. Already in use in Irish hospitals, where it has generated 30% cost-savings per month (based on an independent whitepaper evaluation carried out by Trinity College Dublin), the company is set to launch pilot deployments of its software solution in US hospitals over the coming months.
Staff retention is one of the top financial challenges facing US hospitals today. Hospitals and health systems are under increasing pressure to reduce costs while also improving quality and maintaining a strong workforce. As the largest health care workforce, nurses are at the front-line of patient care. The work environment in which nurses operate determines the quality and safety of patient care. When care falls short of standards because of workforce shortages, health systems will struggle to provide safe, quality care for patients. This may also impact on financial considerations such as hospital readmission rates.
Last month, CliniShift was one of just two Irish companies, invited to pitch to heavy-hitters from US health systems and health insurers at the GlobalSTL Health Innovation Summit, in St Louis, MO. Following a successful pitch, CliniShift has identified key hospital groups and health systems who can significantly benefit from its bespoke software solution. The company plans to open two new offices in Boston, MA and St Louis MO, and recruit senior management in the US this summer.
Commenting on the company’s expansion into the US healthcare market, CEO and Founder of CliniShift, Ms. Aimée Madden, said, “I’m grateful to be part of this exciting journey we’re on and look forward to developing the company to be a best-in-class organization that will continue to add value well into the future.” The Affordable Care Act (ACA) established the Hospital Readmission Reduction Program (HRRP) in 2012. Under this program, hospitals are financially penalized if they have higher than expected risk-standardized 30-day readmission rates for acute myocardial infarction, heart failure, and pneumonia.